- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Undervalued based on future growth
Hong Kong Pharmaceuticals & Biotech Undervalued based on future growth
Results
13
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
13 companies
China Medical System Holdings
Market Cap: HK$24.9b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$10.28
7D
1.1%
1Y
-14.3%
Grand Pharmaceutical Group
Market Cap: HK$16.5b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$4.70
7D
-2.1%
1Y
-46.1%
Consun Pharmaceutical Group
Market Cap: HK$10.6b
Produces and sells pharmaceutical products in Mainland China.
1681
HK$12.58
7D
0.6%
1Y
11.1%
Sihuan Pharmaceutical Holdings Group
Market Cap: HK$7.5b
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China, the United States, and internationally.
460
HK$0.83
7D
-3.5%
1Y
-25.2%
Luye Pharma Group
Market Cap: HK$7.2b
Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.
2186
HK$1.80
7D
-4.3%
1Y
-49.7%
Shanghai Haohai Biological Technology
Market Cap: HK$6.9b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$15.32
7D
-5.4%
1Y
-39.0%
SSY Group
Market Cap: HK$6.1b
An investment holding company, researches, develops, manufactures, trades, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$2.12
7D
-2.3%
1Y
-23.7%
China Shineway Pharmaceutical Group
Market Cap: HK$5.6b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$7.38
7D
-3.5%
1Y
-5.9%
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$5.4b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine products to wholesalers and individuals.
3613
HK$6.47
7D
-0.8%
1Y
-25.4%
Tong Ren Tang Technologies
Market Cap: HK$4.1b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$3.20
7D
-3.3%
1Y
-35.1%
Viva Biotech Holdings
Market Cap: HK$2.4b
An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.
1873
HK$1.13
7D
0.9%
1Y
-26.6%
Jacobson Pharma
Market Cap: HK$2.1b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.04
7D
-2.8%
1Y
-36.2%
Essex Bio-Technology
Market Cap: HK$1.5b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$2.67
7D
1.1%
1Y
-39.5%